Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention - PubMed (original) (raw)

Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention

Mark A Sager et al. J Geriatr Psychiatry Neurol. 2005 Dec.

Abstract

Adult children of persons with Alzheimer's disease are at increased risk of developing Alzheimer's disease because of hereditary, environmental, and health risk factors shared with affected parents. The Wisconsin Registry for Alzheimer's Prevention (WRAP) has completed baseline assessments on 452 middle-aged persons (mean = 53 years) who have at least 1 parent with AD. Forty-five percent had 1 or more apolipoprotein (APOE) epsilon4 alleles. There were few significant differences between epsilon4 carriers and noncarriers in demographics, health, and lifestyle measures or in neuropsychological performance. The high percentage of WRAP participants who are carriers of APOE epsilon4 underscores their increased risk for developing Alzheimer's disease, but the absence of differences related to APOE status and high mean scores on cognitive tests suggests that the APOE epsilon4 gene has yet to have a clinical impact on cognitive functioning. The WRAP cohort may be a valuable group to follow prospectively to characterize the nature of cognitive change in relation to risk factors and to identify underlying preclinical neurobiological changes.

PubMed Disclaimer

Cited by

Heritability of cognitive traits among siblings with a parental history of Alzheimer's disease.
Darst BF, Koscik RL, Hermann BP, La Rue A, Sager MA, Johnson SC, Engelman CD. Darst BF, et al. J Alzheimers Dis. 2015;45(4):1149-55. doi: 10.3233/JAD-142658. J Alzheimers Dis. 2015. PMID: 25649654 Free PMC article.
Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease.
Okonkwo OC, Xu G, Oh JM, Dowling NM, Carlsson CM, Gallagher CL, Birdsill AC, Palotti M, Wharton W, Hermann BP, LaRue A, Bendlin BB, Rowley HA, Asthana S, Sager MA, Johnson SC. Okonkwo OC, et al. Cereb Cortex. 2014 Apr;24(4):978-88. doi: 10.1093/cercor/bhs381. Epub 2012 Dec 12. Cereb Cortex. 2014. PMID: 23236200 Free PMC article.
Interactive effects of physical activity and APOE-ε4 on white matter tract diffusivity in healthy elders.
Smith JC, Lancaster MA, Nielson KA, Woodard JL, Seidenberg M, Durgerian S, Sakaie K, Rao SM. Smith JC, et al. Neuroimage. 2016 May 1;131:102-12. doi: 10.1016/j.neuroimage.2015.08.007. Epub 2015 Aug 8. Neuroimage. 2016. PMID: 26265157 Free PMC article.
Assessing the Biological Mechanisms Linking Smoking Behavior and Cognitive Function: A Mediation Analysis of Untargeted Metabolomics.
Choi JJ, Koscik RL, Jonaitis EM, Panyard DJ, Morrow AR, Johnson SC, Engelman CD, Schmitz LL. Choi JJ, et al. Metabolites. 2023 Nov 16;13(11):1154. doi: 10.3390/metabo13111154. Metabolites. 2023. PMID: 37999250 Free PMC article.
Cardiorespiratory fitness attenuates age-associated aggregation of white matter hyperintensities in an at-risk cohort.
Vesperman CJ, Pozorski V, Dougherty RJ, Law LL, Boots E, Oh JM, Gallagher CL, Carlsson CM, Rowley HA, Ma Y, Bendlin BB, Asthana S, Sager MA, Hermann BP, Johnson SC, Cook DB, Okonkwo OC. Vesperman CJ, et al. Alzheimers Res Ther. 2018 Sep 24;10(1):97. doi: 10.1186/s13195-018-0429-0. Alzheimers Res Ther. 2018. PMID: 30249285 Free PMC article.

Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention - PubMed (original) (raw)